Acrivon Therapeutics shares owned by DAFNA Capital Management
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by DAFNA Capital Management
from 13F filings
Historical chart of DAFNA Capital Management investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by DAFNA Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $787k | 112k | 7.00 |
| 2024-06-30 | $704k | 121k | 5.80 |
| 2024-03-31 | $939k | 131k | 7.15 |
| 2023-12-31 | $646k | 131k | 4.92 |
| 2023-09-30 | $735k | 77k | 9.56 |
| 2023-06-30 | $996k | 77k | 12.96 |
| 2023-03-31 | $649k | 51k | 12.69 |
| 2022-12-31 | $180k | 16k | 11.52 |